D. Jeffrey Keyser is Director at Lantern Pharma Inc. (LTRN). They have made 2 open-market trades across 1 company since 2020, most recently 2026-05-12.
CIK 0001393516
2 open-market purchases totalling $250K since 2020, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| LTRN | 48,544 | $32K |
| ENCY | 74,467 | — |
| ZSPH | 225,323 | — |
| Total | $32K |
Shares reported on the most recent Form 4, priced at the 2026-05-14 close. 2 holdings could not be priced and are excluded from the total.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.